Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
European Journal of Cancer (Oxford, England : 1990)|August 26, 2025
The immune landscape of pediatric (extra)cranial solid tumors: A systematic review and integration of immunohistochemistry and single-cell RNA sequencing dataFrancisca J Bergsma, Jan Koster, Bob Baalman, et al.
British Journal of Haematology|June 10, 2010
Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemiaFrancis Mussai, Dario Campana, Deepa Bhojwani, et al.
Biomed Research International|July 5, 2022
Characterisation of Expression the Arginine Pathway Enzymes in Childhood Brain Tumours to Determine Susceptibility to Therapeutic Arginine DepletionEleanor Bishop, Monika Dimitrova, Alexander Froggatt, et al.
Blood|June 5, 2013
Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironmentFrancis Mussai, Carmela De Santo, Issa Abu-Dayyeh, et al.
Blood|January 14, 2021
Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cellsPaul J Collins, Christopher P Fox, Lindsay George, et al.
Clinical & Translational Immunology|May 23, 2022
G-CSF induces CD15+ CD14+ cells from granulocytes early in the physiological environment of pregnancy and the cancer immunosuppressive microenvironmentEbtehag Maneta, Livingstone Fultang, Jemma Taylor, et al.
Leukemia & Lymphoma|May 24, 2011
Enhancing immunotoxin cell-killing activity via combination therapy with ABT-737David J Fitzgerald, Elizabeth Moskatel, Gal Ben-Josef, et al.
International Journal of Cancer|November 29, 2018
Targeting the arginine metabolic brake enhances immunotherapy for leukaemiaFrancis Mussai, Rachel Wheat, Evgenia Sarrou, et al.
International Journal of Cancer|November 24, 2017
The arginine metabolome in acute lymphoblastic leukemia can be targeted by the pegylated-recombinant arginase I BCT-100Carmela De Santo, Sarah Booth, Ashley Vardon, et al.
Frontiers in Oncology|December 13, 2018
Interactions Between Pseudomonas Immunotoxins and the Plasma Membrane: Implications for CAT-8015 Immunotoxin TherapyMonika Bokori-Brown, Jeremy Metz, Peter G Petrov, et al.
Pageof 4